Ameliorative effects of angiotensin receptor blockers against scopolamine-induced memory impairment in rats

Debasree Deb, Veena Nayak, Laxminarayana Bairy Kurady, Mohandas Rao

Research output: Contribution to journalArticle

Abstract

Objective: The present study was designed to investigate the cognitive enhancing property of angiotensin receptor blockers (ARBs) in scopolamine-induced amnesic rats. Methods: A total of 42 male Wistar rats were divided into seven groups. Group 1 received 2% gum acacia orally for 4 weeks, Group 2 received normal saline, and Group 3 received scopolamine (2 mg/kg/i.p.) as a single dose. Groups 4 and 5 received telmisartan (1.80 mg/kg and 3.60 mg/kg, respectively) while Groups 6 and 7 received losartan (2.25 mg/kg and 4.50 mg/kg, respectively), orally for 4 weeks, followed by scopolamine (2 mg/kg/i.p.) given 45 minutes prior to experimental procedure. Evaluation of learning and memory was assessed by using morris water maze test followed by estimation of hippocampal choline acetyltransferase (ChAT) activity. Alterations in hippocampal morphology and degree of neuronal survival were also analyzed following drug treatments. Results: Scopolamine-induced marked impairment of memory in the behavioral test which correlated with reduced ChAT activity and morphological changes in the hippocampus. Treatment with higher doses of telmisartan and losartan improved memory deficits in scopolamine-induced amnesic rats while increasing the hippocampal ChAT activity. The treatments also attenuated hippocampal degeneration and increased the number of surviving neurons in hippocampus scopolamine-induced amnesic rats. Conclusion: Pre-treatment with ARBs attenuated scopolamine-induced memory deficits which may be attributed to their angiotensin receptor blockade property or to improved cholinergic activity, and thus highlighting the potential of these drugs in dementia.

Original languageEnglish
Pages (from-to)335-341
Number of pages7
JournalAsian Journal of Pharmaceutical and Clinical Research
Volume9
Issue number2
Publication statusPublished - 01-03-2016

Fingerprint

Scopolamine Hydrobromide
Angiotensin Receptor Antagonists
Choline O-Acetyltransferase
Losartan
Memory Disorders
Hippocampus
Gum Arabic
Angiotensin Receptors
Pharmaceutical Preparations
Cholinergic Agents
Dementia
Wistar Rats
Learning
Neurons
Water

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this

@article{c9d82f00d61f4ae6bad5f015810cba45,
title = "Ameliorative effects of angiotensin receptor blockers against scopolamine-induced memory impairment in rats",
abstract = "Objective: The present study was designed to investigate the cognitive enhancing property of angiotensin receptor blockers (ARBs) in scopolamine-induced amnesic rats. Methods: A total of 42 male Wistar rats were divided into seven groups. Group 1 received 2{\%} gum acacia orally for 4 weeks, Group 2 received normal saline, and Group 3 received scopolamine (2 mg/kg/i.p.) as a single dose. Groups 4 and 5 received telmisartan (1.80 mg/kg and 3.60 mg/kg, respectively) while Groups 6 and 7 received losartan (2.25 mg/kg and 4.50 mg/kg, respectively), orally for 4 weeks, followed by scopolamine (2 mg/kg/i.p.) given 45 minutes prior to experimental procedure. Evaluation of learning and memory was assessed by using morris water maze test followed by estimation of hippocampal choline acetyltransferase (ChAT) activity. Alterations in hippocampal morphology and degree of neuronal survival were also analyzed following drug treatments. Results: Scopolamine-induced marked impairment of memory in the behavioral test which correlated with reduced ChAT activity and morphological changes in the hippocampus. Treatment with higher doses of telmisartan and losartan improved memory deficits in scopolamine-induced amnesic rats while increasing the hippocampal ChAT activity. The treatments also attenuated hippocampal degeneration and increased the number of surviving neurons in hippocampus scopolamine-induced amnesic rats. Conclusion: Pre-treatment with ARBs attenuated scopolamine-induced memory deficits which may be attributed to their angiotensin receptor blockade property or to improved cholinergic activity, and thus highlighting the potential of these drugs in dementia.",
author = "Debasree Deb and Veena Nayak and Kurady, {Laxminarayana Bairy} and Mohandas Rao",
year = "2016",
month = "3",
day = "1",
language = "English",
volume = "9",
pages = "335--341",
journal = "Asian Journal of Pharmaceutical and Clinical Research",
issn = "0974-2441",
publisher = "Innovare Academics Sciences Pvt. Ltd",
number = "2",

}

Ameliorative effects of angiotensin receptor blockers against scopolamine-induced memory impairment in rats. / Deb, Debasree; Nayak, Veena; Kurady, Laxminarayana Bairy; Rao, Mohandas.

In: Asian Journal of Pharmaceutical and Clinical Research, Vol. 9, No. 2, 01.03.2016, p. 335-341.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Ameliorative effects of angiotensin receptor blockers against scopolamine-induced memory impairment in rats

AU - Deb, Debasree

AU - Nayak, Veena

AU - Kurady, Laxminarayana Bairy

AU - Rao, Mohandas

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Objective: The present study was designed to investigate the cognitive enhancing property of angiotensin receptor blockers (ARBs) in scopolamine-induced amnesic rats. Methods: A total of 42 male Wistar rats were divided into seven groups. Group 1 received 2% gum acacia orally for 4 weeks, Group 2 received normal saline, and Group 3 received scopolamine (2 mg/kg/i.p.) as a single dose. Groups 4 and 5 received telmisartan (1.80 mg/kg and 3.60 mg/kg, respectively) while Groups 6 and 7 received losartan (2.25 mg/kg and 4.50 mg/kg, respectively), orally for 4 weeks, followed by scopolamine (2 mg/kg/i.p.) given 45 minutes prior to experimental procedure. Evaluation of learning and memory was assessed by using morris water maze test followed by estimation of hippocampal choline acetyltransferase (ChAT) activity. Alterations in hippocampal morphology and degree of neuronal survival were also analyzed following drug treatments. Results: Scopolamine-induced marked impairment of memory in the behavioral test which correlated with reduced ChAT activity and morphological changes in the hippocampus. Treatment with higher doses of telmisartan and losartan improved memory deficits in scopolamine-induced amnesic rats while increasing the hippocampal ChAT activity. The treatments also attenuated hippocampal degeneration and increased the number of surviving neurons in hippocampus scopolamine-induced amnesic rats. Conclusion: Pre-treatment with ARBs attenuated scopolamine-induced memory deficits which may be attributed to their angiotensin receptor blockade property or to improved cholinergic activity, and thus highlighting the potential of these drugs in dementia.

AB - Objective: The present study was designed to investigate the cognitive enhancing property of angiotensin receptor blockers (ARBs) in scopolamine-induced amnesic rats. Methods: A total of 42 male Wistar rats were divided into seven groups. Group 1 received 2% gum acacia orally for 4 weeks, Group 2 received normal saline, and Group 3 received scopolamine (2 mg/kg/i.p.) as a single dose. Groups 4 and 5 received telmisartan (1.80 mg/kg and 3.60 mg/kg, respectively) while Groups 6 and 7 received losartan (2.25 mg/kg and 4.50 mg/kg, respectively), orally for 4 weeks, followed by scopolamine (2 mg/kg/i.p.) given 45 minutes prior to experimental procedure. Evaluation of learning and memory was assessed by using morris water maze test followed by estimation of hippocampal choline acetyltransferase (ChAT) activity. Alterations in hippocampal morphology and degree of neuronal survival were also analyzed following drug treatments. Results: Scopolamine-induced marked impairment of memory in the behavioral test which correlated with reduced ChAT activity and morphological changes in the hippocampus. Treatment with higher doses of telmisartan and losartan improved memory deficits in scopolamine-induced amnesic rats while increasing the hippocampal ChAT activity. The treatments also attenuated hippocampal degeneration and increased the number of surviving neurons in hippocampus scopolamine-induced amnesic rats. Conclusion: Pre-treatment with ARBs attenuated scopolamine-induced memory deficits which may be attributed to their angiotensin receptor blockade property or to improved cholinergic activity, and thus highlighting the potential of these drugs in dementia.

UR - http://www.scopus.com/inward/record.url?scp=84960074940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960074940&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 335

EP - 341

JO - Asian Journal of Pharmaceutical and Clinical Research

JF - Asian Journal of Pharmaceutical and Clinical Research

SN - 0974-2441

IS - 2

ER -